Update to coagulopathy in COVID-19: Manifestations and management.
Cleve Clin J Med
; 2021 Jun 02.
Article
en En
| MEDLINE
| ID: mdl-33323363
ABSTRACT
Severe COVID-19 illness is associated with intense inflammation, leading to high rates of thrombotic complications that increase morbidity and mortality. Markedly elevated levels of D-dimer with normal fibrinogen levels are the hallmark laboratory findings of severe COVID-19-associated coagulopathy. Prophylaxis against venous thromboembolism is paramount for all hospitalized patients with COVID-19, with more aggressive prophylaxis and screening recommended for critically ill patients with D-dimer levels above 3.0 µg/mL. Point-of-care ultrasonography is the imaging method of choice for patients at high risk, as it entails minimal risk of exposing providers to the virus.
Texto completo:
1
Base de datos:
MEDLINE
Idioma:
En
Revista:
Cleve Clin J Med
Asunto de la revista:
MEDICINA
Año:
2021
Tipo del documento:
Article